AxoGen Company
AxoGen is a biotech company developing treatment options for the reconstruction and repair of peripheral nerve injuries.
Technology:
Bioengineering, Other
Industry:
BioEngineering, Public
Headquarters:
Alachua, Florida, United States
Founded Date:
2002-01-01
Employees Number:
251-500
Funding Status:
IPO
Investors Number:
5
Total Funding:
69919779
Estimated Revenue:
$10M to $50M
Last Funding Date:
2015-08-28
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership